Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Pediatric mesothelioma- A disease of a kind

Study of recovered COVID-19 patients with repeated positive RT-PCR findings in Wuhan, China

Cancer Vaccines: A Concoction Strategy to fight Leukemia

Pediatric mesothelioma- A disease of a kind
  • BiotechToday
  • World

Pediatric mesothelioma- A disease of a kind

bioxone October 15, 2020October 15, 2020

Sashreek Ganguli, Amity University Kolkata

Mesothelioma is a tumour caused by intake of asbestos fibers and forms within the peritoneum of lungs. The occurrence rate is high in people belonging to the age bracket of 80-84 years. To treat this, pemetrexed-based regimen with cytoreductive surgery (CRS) could be a commonly used, but long-term survival is rare with lifespan up to 12-21months, after diagnosis.

Apart from the adults, the paediatric population is simultaneously affected by the condition. Here it’s imperative to say that little was known about the characteristics of mesothelial tumors within the pediatric population. Hence, to further the knowledge on the condition in adolescents, scientists at the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT) reviewed past paediatric cases(1987-2018). They identified 33 patients and discovered the first tumour mainly within the peritoneum (23 patients).

The histology was multicystic mesothelioma in the peritoneum (MCM) (6 cases) or malignant mesothelioma (MM) (27 cases). There was documented evidence of exposure to asbestos in one case. Within, MM the response to permetrexed was 50% (i.e. 6/12) and survival rate to CRS-Hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) after a follow-up of 6.7 years (range, 0–20), five-year overall and event-free survivals were 82.3% (95% CI, confidential interval ((CI), 67.8–99.9) and 45.1% (95% CI, 28.4–71.7), respectively. In MCM, all patients survived after surgery and CRS-HIPEC. Conclusively, paediatric mesothelioma is different from its adult form with lesser asbestos exposures, more primary tumours in the peritoneum. The cisplatin–pemetrexed regimen showed good efficacy.

Also read: Covid-19 affects Brain directly?- Study revealed

Source: https://doi.org/10.1016/j.ejca.2020.09.011

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Adolescents Asbestos cancer CRS CRS-HIPEC EXPeRT lung malignancy Mesothelioma Paediatric Peritoneum

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Cancer Vaccines: A Concoction Strategy to fight Leukemia

bioxone October 15, 2020

Chitra Roy, University of Calcutta Leukemia is a malignancy of blood cells that starts to develop when the DNA of a single cell in the bone marrow mutates and fails to develop and function properly. These leukemia cells crowd out normal blood cells, making it difficult for the normal cells to do their job. Chronic […]

Leukemia

Related Post

  • World

Can a gene expression be visualized non-invasively?

bioxone September 23, 2020September 23, 2020

– Husna, Amity University Kolkata Visualizing gene expression, protein localization, and other cellular activities via special equipment, expensive chemicals, or invasive treatments are quite commonly done through Reporters. For instance, the β-glucuronidase (GUS) and luciferase are broadly used reporters that require the addition of expensive substrates X-Gluc and luciferin, respectively. Moreover, GUS-staining is invasive. Luciferase […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

New use for an old drug: How does ketamine combat depression?

bioxone December 25, 2020December 25, 2020

Sagnik Nag, Amity University, Kolkata According to researchers from three Canadian universities, a group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain. The discovery could throw light upon better and safer treatments for certain patients suffering from clinical depression. Unlike standard antidepressants, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India
  • World

Here’s how COVID-19 vaccine BNT162b1 produces human antibody and helper T-cell responses

bioxone October 4, 2020October 4, 2020

Ayooshi Mitra, Amity University Kolkata To avert the spread of the pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a successful vaccine is needed. In an examination directed recently, safety, tolerability, and neutralizer reaction information from an on-going placebo-controlled treatment observer-blinded phase 1/2 coronavirus disease 2019 (COVID-19) vaccine trial BNT162b1, a lipid nanoparticle (LNP) nucleoside-modified […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy